Ethical Considerations in Adaptive Design Clinical Trials

Therapeutic Innovation & Regulatory Science
Thomas LaageChristopher Coffey

Abstract

Adaptive design clinical trial methodologies offer both opportunities and challenges for observing basic ethical principles in human subject research. Using both published and unpublished adaptive design clinical trials, we have selected and reviewed examples of clinical trials with different design adaptations to discuss the ethical obstacles presented and often successfully resolved by these approaches, including (1) confirmatory trials for treatments widely accepted on the basis of uncontrolled case series or open-label trials (clinical equipoise and "justice" in the sense of which trial groups will "receive the benefits of research and bear its burdens") (infantile hemangioma/propranolol); (2) interim results analysis by unblinded data monitoring committees ("withholding information necessary to make a considered judgment" ["respect for persons"] versus compromising the trial's scientific basis) (BIG 1-98); (3) adaptations involving sample size reassessment or dose adjustment via dropping or adding treatment arms, allowing fewer subjects to produce statistically significant results, fewer subjects treated with ineffective/toxic doses, and more subjects given doses showing tolerance and treatment activity ("beneficence" or "...Continue Reading

References

May 31, 1979·The New England Journal of Medicine·M Zelen
Mar 31, 1998·BMJ : British Medical Journal·D J Torgerson, M Roland
Oct 3, 2002·Statistical Methods in Medical Research·Peter F Thall
Dec 31, 2005·The New England Journal of Medicine·UNKNOWN Breast International Group (BIG) 1-98 Collaborative GroupAron Goldhirsch
Nov 28, 2006·Pharmaceutical Statistics·Christy Chuang-Stein
Nov 30, 2007·PLoS Medicine·Gail E HendersonCatherine R Zimmer
Dec 16, 2011·The New England Journal of Medicine·Badrul A ChowdhuryCurtis J Rosebraugh
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mothaffar Rimawi, Susan G Hilsenbeck
May 30, 2012·Pharmaceutical Statistics·S KirbyC Sin
Jun 14, 2012·JAMA : the Journal of the American Medical Association·William J MeurerDonald A Berry
Dec 20, 2012·Clinical Trials : Journal of the Society for Clinical Trials·Christopher S CoffeySara Harris
Jan 16, 2014·Annual Review of Medicine·Shein-Chung Chow
Feb 5, 2015·Clinical Trials : Journal of the Society for Clinical Trials·Spencer Phillips Hey, Jonathan Kimmelman
Feb 19, 2015·The New England Journal of Medicine·Christine Léauté-LabrèzeJean-Jacques Voisard
Mar 18, 2015·Statistics in Medicine·Peter BauerGernot Wassmer
Mar 24, 2015·JAMA : the Journal of the American Medical Association·Scott M BerryRoger J Lewis
May 17, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ThallJ Wathen
Dec 17, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Bruce Ac CreeEliezer Katz
Mar 20, 2016·British Journal of Anaesthesia·S HeschlM Rigaud
Jul 15, 2016·The New England Journal of Medicine·Deepak L Bhatt, Cyrus Mehta

❮ Previous
Next ❯

Citations

Nov 25, 2017·The Hastings Center Report·Laura E Bothwell, Aaron S Kesselheim
Feb 20, 2021·Contemporary Clinical Trials Communications·Adam P SimaJeffrey S Kreutzer
Jul 6, 2020·Clinical Therapeutics·Elias Laurin MeyerFranz König
Feb 11, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raymond U OsarogiagbonJames L Wade
Aug 8, 2021·Journal of Medical Ethics·Michael Os Afolabi, Lauren E Kelly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Boris Freidlin, Edward L Korn
Srpski arhiv za celokupno lekarstvo
Andrijana Milosević GeorgievValentina Marinković
© 2022 Meta ULC. All rights reserved